Ultrastructural observation of filtration membrane in cell-free and concentrated ascites reinfusion therapy for malignant ascites

Ther Apher Dial. 2022 Jun;26(3):649-657. doi: 10.1111/1744-9987.13747. Epub 2021 Oct 28.

Abstract

Introduction: Cell-free and concentrated ascites reinfusion therapy (CART) is used for the treatment of diuretic-resistant ascites. An increase in circuit pressure and clogging of the filtration membrane often occur in CART for malignant ascites.

Methods: To clarify the precise mechanism of filter clogging, we performed an ultrastructural observation study of the filtration membrane after the filtration of malignant ascites.

Results: The deposition on the filtration membrane was composed of blood cells, fibrin, or both. Cellular deposition was associated with a greater number of blood cells in the original ascites fluid. In contrast, fibrin deposition was associated with higher levels of interleukin-6, α1-antitrypsin, haptoglobin, and fibrinogen/fibrin degradation products.

Conclusion: Our results suggest that the specific pathophysiologies of malignancy (such as inflammation or coagulation/fibrinolysis) and characteristics of malignant ascites (highly concentrated and cell-rich) are associated with clogging of the filtration membrane during CART.

Keywords: ascites; cancer; filtration; membranes; scanning electron microscopy.

MeSH terms

  • Ascites* / etiology
  • Ascites* / pathology
  • Ascites* / therapy
  • Ascitic Fluid / metabolism
  • Fibrin / metabolism
  • Filtration / methods
  • Humans
  • Peritoneal Neoplasms* / complications
  • Treatment Outcome

Substances

  • Fibrin